Citation: M. Sculpher, THE COST-EFFECTIVENESS OF PREFERENCE-BASED TREATMENT ALLOCATION - THECASE OF HYSTERECTOMY VERSUS ENDOMETRIAL RESECTION IN THE TREATMENT OFMENORRHAGIA, Health economics, 7(2), 1998, pp. 129-142
Citation: M. Sculpher et B. Obrien, INCOME EFFECTS OF REDUCED HEALTH AND HEALTH-EFFECTS OF REDUCED INCOME- IMPLICATIONS FOR QALY MEASUREMENT, Medical decision making, 18(4), 1998, pp. 483-483
Citation: B. Obrien et M. Sculpher, EXTENDED DOMINANCE IN COST-EFFECTIVENESS DECISION RULES - FINE IN PRINCIPLE BUT, Medical decision making, 18(4), 1998, pp. 488-488
Citation: M. Sculpher, A COST-UTILITY ANALYSIS OF ABDOMINAL HYSTERECTOMY VERSUS TRANSCERVICAL ENDOMETRIAL RESECTION FOR THE SURGICAL-TREATMENT OF MENORRHAGIA, International journal of technology assessment in health care, 14(2), 1998, pp. 302-319
Citation: M. Sculpher et J. Brown, A SYSTEMATIC REVIEW OF HEALTH BENEFIT VALUATION IN ECONOMIC EVALUATIONS IN CANCER, European journal of cancer, 33, 1997, pp. 25-25
Citation: A. Briggs et al., COST-EFFECTIVENESS OF SCREENING FOR AND ERADICATION OF HELICOBACTER-PYLORI IN YOUNG-PATIENTS WITH DYSPEPSIA - REPLY, BMJ. British medical journal, 313(7057), 1996, pp. 623-623
Authors:
KOHNER E
ALLWINKLE J
ANDREWS J
BAKER R
BROWN F
CHENG H
GRAY M
GRINDEY S
KOPPEL I
MARTIN B
RECKLESS J
ROTHMAN D
SCULPHER M
TALBOT F
VAUGHAN N
WILKINSON J
Citation: E. Kohner et al., REPORT OF THE VISUAL HANDICAP GROUP, Diabetic medicine, 13(9), 1996, pp. 13-26
Authors:
SCHULMAN KA
BUXTON M
GLICK H
SCULPHER M
GUZMAN G
KONG J
BACKHOUSE M
MAUSKOPF J
BELL L
EISENBERG JM
CALIFF RM
MCKENNA WJ
HARRELL FE
URETSKY BF
ADAMS KF
SWEDBERG KB
GHEORGHIADE M
ZANNAD F
HANDBERG E
DARIUS H
SOLERSOLER J
WHEELER WS
ARMSTRONG PW
PATTERSON H
MURALI S
BUTMAN S
KIRLIN PC
MILLER LW
JAFRI S
RICH S
COSTANZONORDIN MR
MCGOON M
HOSENPUD JD
RATKOVEC R
BRUNDAGE B
PRITZKER M
BOURGE R
REEVES W
FORGOSH L
VENTURA H
YOUNG JB
MANCINI D
MILLS RM
LIMACHER MC
LEE F
REVKIN J
KALBFLEISCH JM
FISHBEIN D
PRESSLER M
HAEUSSLEIN E
KARLSBERG RP
OCONNELL J
LEJEMTEL TH
THOMAS HM
SMITH WB
MCIVOR M
CINTRON GB
HAGER WD
MESSINEO FC
DOUGHERTY JE
HASSAPOYANNES C
HOOD W
MCGREW F
SANFORD CF
OCONNER CM
HOBBS RE
YARDLEY D
KAY R
MINOTTI J
EASTBURN TE
LINDENFELD J
LITMAN G
WICKEMEYER W
HORTON S
GILBERT EM
EICHORN E
RIBNER HS
CORDER C
PHILBIN E
NOCERO M
ELKAYAM U
JESSUP M
CRAWFORD M
CARSON P
REDDY HK
KLAPHOLZ M
HEYWOOD JT
SALINGER M
KARLSBERG R
BUSH D
HUNTER C
WOHNS D
EISENBERG P
WINSTON S
BUTCHER C
MASSIN E
WYNNE J
TONKON M
SPACCAVENTO L
DIVER D
GHALI J
HUTCHINS S
ANAND I
BEANLANDS D
KOSTUK W
PFLUGFELDER P
LANGLEBEN D
LATOUR P
MIZGALA H
RICCI D
MANYARI D
DARGIE HJ
DAVIDSON C
SWANTON H
HUBNER PJB
OAKLEY D
BROOKS N
JENNINGS K
GREENBAUM RA
PENNY WJ
NICHOLLS P
WALSH M
SUGRUE D
FENNELL W
HORGAN JH
JONDEAU G
CASTAIGNE A
LEMAREC H
WALGER P
PARK JW
DEBERRAZUETA JR
MOL MG
SANCHEZ MAG
CAPONNETTO S
MAGNANI B
GALIE N
DEVITA C
MASERI A
BAGGER JP
REMES J
WALDENSTROM A
SCHAUFELBERGER M
DIENSTI F
SIMOONS ML
KLEIN W
PACHER R
KEOGH A
HARLEY A
Citation: Ka. Schulman et al., RESULTS OF THE ECONOMIC-EVALUATION OF THE FIRST STUDY - A MULTINATIONAL PROSPECTIVE ECONOMIC-EVALUATION, International journal of technology assessment in health care, 12(4), 1996, pp. 698-713
Citation: M. Sculpher et al., A COST-UTILITY ANALYSIS OF LASER-ASSISTED ANGIOPLASTY FOR PERIPHERAL ARTERIAL OCCLUSIONS, International journal of technology assessment in health care, 12(1), 1996, pp. 104-125
Authors:
SCHULMAN KA
GLICK H
BUXTON M
SCULPHER M
BACKHOUSE M
BELL L
EISENBERG JM
Citation: Ka. Schulman et al., THE ECONOMIC-EVALUATION OF THE FIRST STUDY - DESIGN OF A PROSPECTIVE ANALYSIS ALONGSIDE A MULTINATIONAL PHASE-III CLINICAL-TRIAL, Controlled clinical trials, 17(4), 1996, pp. 304-315
Citation: A. Briggs et M. Sculpher, SENSITIVITY ANALYSIS IN ECONOMIC-EVALUATION - A REVIEW OF PUBLISHED STUDIES, Health economics, 4(5), 1995, pp. 355-371
Citation: M. Sculpher et M. Buxton, EPISODE-FREE DAYS AS END-POINTS IN ECONOMIC EVALUATIONS OF ASTHMA THERAPY - REPLY, PharmacoEconomics, 5(1), 1994, pp. 78-79
Citation: A. Briggs et al., UNCERTAINTY IN THE ECONOMIC-EVALUATION OF HEALTH-CARE TECHNOLOGIES - THE ROLE OF SENSITIVITY ANALYSIS, Health economics, 3(2), 1994, pp. 95-104
Citation: J. Michaels et al., SELF-VALUATION OF HEALTH-RELATED QUALITY-OF-LIFE AND UTILITY IN PATIENTS WITH VASCULAR-DISEASE, British Journal of Surgery, 81(4), 1994, pp. 621-621